[{"address1": "9237 East Via de Ventura Boulevard", "address2": "Suite 105", "city": "Scottsdale", "state": "AZ", "zip": "85258", "country": "United States", "phone": "480 434 6670", "website": "https://journeymedicalcorp.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also offers Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Exelderm for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Emrosi for the treatment of inflammatory lesions of rosacea, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.", "fullTimeEmployees": 41, "companyOfficers": [{"maxAge": 1, "name": "Dr. Lindsay Allan Rosenwald M.D.", "age": 69, "title": "Executive Chairman", "yearBorn": 1955, "fiscalYear": 2024, "totalPay": 50000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Claude  Maraoui", "age": 57, "title": "Founder, President, CEO & Director", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 975434, "exercisedValue": 0, "unexercisedValue": 4806250}, {"maxAge": 1, "name": "Mr. Joseph M. Benesch", "age": 57, "title": "CFO & Corporate Controller", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 434088, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ramsey  Alloush", "age": 38, "title": "COO, General Counsel & Company Secretary", "yearBorn": 1986, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Nevin", "age": 55, "title": "Chief Commercial Officer", "yearBorn": 1969, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Jaclyn  Jaffe", "title": "Senior Director of Corporate Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Louis  Donati", "title": "Director of Market Access", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.27, "open": 7.27, "dayLow": 7.07, "dayHigh": 7.27, "regularMarketPreviousClose": 7.27, "regularMarketOpen": 7.27, "regularMarketDayLow": 7.07, "regularMarketDayHigh": 7.27, "payoutRatio": 0.0, "beta": 0.811, "forwardPE": -120.16667, "volume": 130307, "regularMarketVolume": 130307, "averageVolume": 165119, "averageVolume10days": 137560, "averageDailyVolume10Day": 137560, "bid": 7.14, "ask": 7.28, "bidSize": 1, "askSize": 1, "marketCap": 175766816, "fiftyTwoWeekLow": 3.535, "fiftyTwoWeekHigh": 8.9, "priceToSalesTrailing12Months": 3.1165986, "fiftyDayAverage": 7.2392, "twoHundredDayAverage": 6.0779, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 180750720, "profitMargins": -0.15494001, "floatShares": 12063302, "sharesOutstanding": 18378200, "sharesShort": 1445130, "sharesShortPriorMonth": 1114431, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.059299998, "heldPercentInsiders": 0.3652, "heldPercentInstitutions": 0.36047, "shortRatio": 8.49, "shortPercentOfFloat": 0.1114, "impliedSharesOutstanding": 24608800, "bookValue": 0.82, "priceToBook": 8.792683, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -8738000, "trailingEps": -0.37, "forwardEps": -0.06, "enterpriseToRevenue": 3.205, "enterpriseToEbitda": -61.564, "52WeekChange": 0.5052192, "SandP52WeekChange": 0.16844666, "quoteType": "EQUITY", "currentPrice": 7.21, "targetHighPrice": 13.0, "targetLowPrice": 10.0, "targetMeanPrice": 11.8, "targetMedianPrice": 12.0, "recommendationMean": 1.2, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 20293000, "totalCashPerShare": 0.832, "ebitda": -2936000, "totalDebt": 25277000, "quickRatio": 0.888, "currentRatio": 1.266, "totalRevenue": 56397000, "debtToEquity": 131.336, "revenuePerShare": 2.567, "returnOnAssets": -0.058590002, "returnOnEquity": -0.57221, "grossProfits": 37517000, "freeCashflow": -14288125, "operatingCashflow": -2706000, "revenueGrowth": 0.01, "grossMargins": 0.66523004, "ebitdaMargins": -0.052059997, "operatingMargins": -0.19162, "financialCurrency": "USD", "symbol": "DERM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": true, "customPriceAlertConfidence": "HIGH", "postMarketTime": 1756497845, "regularMarketTime": 1756497601, "exchange": "NCM", "messageBoardId": "finmb_280596341", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.825309, "regularMarketPrice": 7.21, "corporateActions": [], "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1636727400000, "postMarketChangePercent": 0.0, "postMarketPrice": 7.21, "postMarketChange": 0.0, "regularMarketChange": -0.0599999, "regularMarketDayRange": "7.07 - 7.27", "fullExchangeName": "NasdaqCM", "shortName": "Journey Medical Corporation", "longName": "Journey Medical Corporation", "marketState": "CLOSED", "averageDailyVolume3Month": 165119, "fiftyTwoWeekLowChange": 3.675, "fiftyTwoWeekLowChangePercent": 1.039604, "fiftyTwoWeekRange": "3.535 - 8.9", "fiftyTwoWeekHighChange": -1.6899996, "fiftyTwoWeekHighChangePercent": -0.1898876, "fiftyTwoWeekChangePercent": 50.521923, "earningsTimestamp": 1755028800, "earningsTimestampStart": 1762977600, "earningsTimestampEnd": 1762977600, "earningsCallTimestampStart": 1755030600, "earningsCallTimestampEnd": 1755030600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.37, "epsForward": -0.06, "fiftyDayAverageChange": -0.029200077, "fiftyDayAverageChangePercent": -0.0040336056, "twoHundredDayAverageChange": 1.1321001, "twoHundredDayAverageChangePercent": 0.186265, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-11-12", "averageAnalystRating": "1.2 - Strong Buy", "cryptoTradeable": false, "trailingPegRatio": null, "__fetch_time": "2025-08-30"}]